Unknown PHASE2 INTERVENTIONAL 1-arm NCT02064062

Autologous Stem Cells in Achilles Tendinopathy (ASCAT)

Sponsor: University College, London

Conditions Achilles Degeneration Achilles Tendinitis Achilles Tendinitis, Left Leg Achilles Tendinitis, Right Leg Achilles Tendon Thickening Tendinopathy

Interventions Autologous Mesenchymal Stem Cells

Updated 6 times since 2017 Last updated: May 11, 2016 Started: Jan 31, 2015 Primary completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02064062, this PHASE2 trial focuses on Achilles Degeneration and Achilles Tendinitis and remains ongoing. Sponsored by University College, London, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University College, London

Data source: University College, London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom